11-89191418-G-A
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_000372.5(TYR):c.1036G>A(p.Gly346Arg) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000992 in 1,612,386 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 15/25 in silico tools predict a damaging outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G346E) has been classified as Pathogenic.
Frequency
Consequence
NM_000372.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TYR | NM_000372.5 | c.1036G>A | p.Gly346Arg | missense_variant, splice_region_variant | 2/5 | ENST00000263321.6 | NP_000363.1 | |
TYR | XM_011542970.3 | c.1036G>A | p.Gly346Arg | missense_variant, splice_region_variant | 2/6 | XP_011541272.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TYR | ENST00000263321.6 | c.1036G>A | p.Gly346Arg | missense_variant, splice_region_variant | 2/5 | 1 | NM_000372.5 | ENSP00000263321.4 | ||
TYR | ENST00000526139.1 | n.1097G>A | splice_region_variant, non_coding_transcript_exon_variant | 2/3 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152000Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000959 AC: 14AN: 1460386Hom.: 0 Cov.: 30 AF XY: 0.00000551 AC XY: 4AN XY: 726566
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152000Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74224
ClinVar
Submissions by phenotype
Oculocutaneous albinism Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Aug 28, 2019 | A heterozygous missense variant was identified, NM_000372.4(TYR):c.1036G>A in exon 2 of 5 of the TYR gene. This substitution is predicted to create a major amino acid change from glycine to arginine at position 346 of the protein, NP_000363.1(TYR):p.(Gly346Arg). The glycine at this position has very high conservation (100 vertebrates, UCSC), and is located within the Tyrosinase functional domain. In silico software predicts this variant to be pathogenic (PolyPhen, SIFT, CADD, MutationTaster). The variant is present in the gnomAD population database at a frequency of 0.003% (1 heterozygote, 0 homozygotes). The variant has been previously reported as pathogenic in patients with oculocutaneous albinism type I (ClinVar, Mauri, L. et al. (2017), Monferme, S. et al. (2018)). Two different variants in the same codon resulting in changes to valine (ClinVar, Miyamura, Y. et al. (2005), Mondal M. et al. (2016)) and glutamic acid (Ghodsinejad Kalahroudi, V. et al. (2014), Monferme, S. et al. (2018), Zhong, Z. et al. (2019)) have also been reported in patient’s with oculocutaneous albinism type I. Based on information available at the time of curation, this variant has been classified as PATHOGENIC. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 27, 2022 | This variant is present in population databases (no rsID available, gnomAD 0.007%). This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 346 of the TYR protein (p.Gly346Arg). This variant also falls at the last nucleotide of exon 2, which is part of the consensus splice site for this exon. This missense change has been observed in individual(s) with oculocutaneous albinism (PMID: 27734839, 29345414). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 1477155). - |
SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Dec 10, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at